生物药产业合力突围:一款新型长效激素的本土化落地样本

E药经理人
Jul 04, 2025

在生物药管线冲刺迈入“兑现期”前,如何将高技术壁垒的创新药物真正推向商业化,成为Biotech绕不开的现实大考。面对复杂制剂开发中的技术挑战与体系协同难题,维升药业与药明生物通过一场围绕新型长效生长激素的深度合作,探索出一条从技术共建到产业转化的可行路径,也为行业提供了新的协同范式。过去十年,全球新药研发IND数量井喷,PD-1、CD47 、GLP-1、ADC、双抗,热门靶点与新技术密集亮相,一场...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10